Northwest Biotherapeutics | Ativo Circulante





Ativo Circulante Alterar Data
Agenus USD 133.95M 120.61M 2025-09
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celldex Therapeutics USD 604.34M 44.06M 2025-09
Eisai JPY 840.88B 50.18B 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Merck USD 47.56B 10.49B 2025-09
Northwest Biotherapeutics USD 7.2M 1.04M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Plus Therapeutics USD 9.83M 1.75M 2023-12
Roche Holding CHF 38.73B 3.03B 2025-12


Northwest Biotherapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.